Artemis Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was USD 0.07766 million compared to USD 0.003377 million a year ago. Net loss was USD 0.404681 million compared to USD 0.078667 million a year ago. Basic loss per share from continuing operations was USD 0.0041 compared to USD 0.001 a year ago.